Spinal cord injury (SCI) is one of the most debilitating of all the traumatic conditions that
afflict individuals. For a number of years, extensive studies have been conducted to clarify …

Traumatic spinal cord injuries are major health problems and the underlying
pathophysiological events and treatment strategies are currently under investigation. In this …

Acute spinal cord injury (SCI) is devastating for patients and their caretakers and has an
annual incidence of 20–50 per million people. Following initial assessment with appropriate …

Therapeutic strategies for the spinal cord injury (SCI) are limited by the current available
drug delivery techniques. Here, an in situ gelling drug delivery system (DDS), composed of a …

Spinal cord injury (SCI) is an incurable condition, in which a cascade of cellular and
molecular events triggered by inflammation and excitotoxicity impairs endogenous …

OBJECTIVES: To evaluate the functional and histological effects of estrogen as a
neuroprotective agent after a standard experimentally induced spinal cord lesion …

Study design: Experimental, controlled, animal study. Objectives: To evaluate the functional
effect of hyperbaric oxygen therapy administered shortly, one day after, and no intervention …

Objective: To evaluate the effect of monosialoganglioside (GM-1) in spinal cord trauma
patients seen in our service who have not been treated with methylprednisolone. Methods …

Study design: Experimental, controlled, animal study. Objectives: To evaluate the influences
of antidepressant treatment, treadmill gait training and a combination of these therapies in …

Ganglioside GM1 is a class of glycolipids predominantly located in the nervous system.
Comprising a ceramide anchor and an oligosaccharide chain containing sialic acid, GM1 …